Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. UMB Financial Corporation

10.7% sales growth and 7.26% return on equity

UMB Financial Corporation operates as the bank holding company for the UMB Bank that provides various banking and other financial services.

UMB Financial Corporation’s sales growth this year is anticipated to be 10.3% and a negative 3.2% for next year.

Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 1.02B for the twelve trailing months.

UMB Financial Corporation’s sales growth for the next quarter is 10.7%. The company’s growth estimates for the present quarter and the next is 59.3% and 1871.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.26%.

UMB Financial Corporation’s Stock Yearly Top and Bottom Value

UMB Financial Corporation’s stock is valued at $67.70 at 04:22 EST, under its 52-week high of $72.76 and way above its 52-week low of $39.47.

UMB Financial Corporation’s Moving Average

UMB Financial Corporation’s worth is above its 50-day moving average of $66.72 and way above its 200-day moving average of $55.59.

2. MorphoSys AG

176.9% sales growth and 12.31% return on equity

MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.

MorphoSys AG’s sales growth this year is anticipated to be 362.4% and a negative 31.1% for next year.

Year-on-year quarterly revenue growth grew by 76.4%, now sitting on N/A for the twelve trailing months.

MorphoSys AG’s sales growth for the next quarter is 176.9%. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and 61.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31%.

MorphoSys AG’s Stock Yearly Top and Bottom Value

MorphoSys AG’s stock is valued at $28.45 at 04:22 EST, way below its 52-week high of $37.96 and way higher than its 52-week low of $18.21.

MorphoSys AG’s Moving Average

MorphoSys AG’s value is higher than its 50-day moving average of $26.87 and below its 200-day moving average of $30.27.

3. Veeva Systems Inc.

24.9% sales growth and 18.73% return on equity

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

Veeva Systems Inc.’s sales growth this year is anticipated to be 31.2% and 18.5% for next year.

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 1.38B for the twelve trailing months.

Veeva Systems Inc.’s sales growth for the next quarter is 24.9%. The company’s growth estimates for the ongoing quarter and the next is 25.9% and 10.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.73%.

Veeva Systems Inc.’s Stock Yearly Top and Bottom Value

Veeva Systems Inc.’s stock is valued at $264.05 at 04:22 EST, way under its 52-week high of $313.99 and way above its 52-week low of $118.11.

Veeva Systems Inc.’s Moving Average

Veeva Systems Inc.’s worth is under its 50-day moving average of $275.20 and above its 200-day moving average of $262.06.

Previous days news about Veeva Systems Inc.

Integra lifesciences selects veeva vault CDMS for clinical data management. According to Business Insider on Tue Dec 15, "Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. "

4. Pinnacle Financial Partners, Inc.

12.4% sales growth and 6.55% return on equity

Pinnacle Financial Partners, Inc., together with its subsidiaries, operates as the bank holding company for Pinnacle Bank that provides various banking products and services in the United States.

Pinnacle Financial Partners, Inc.’s sales growth this year is anticipated to be 12.4% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 898.13M for the twelve trailing months.

Pinnacle Financial Partners, Inc.’s sales growth for the next quarter is 12.4%. The company’s growth estimates for the current quarter and the next is 4.7% and 232.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.55%.

Pinnacle Financial Partners, Inc.’s Stock Yearly Top and Bottom Value

Pinnacle Financial Partners, Inc.’s stock is valued at $60.01 at 04:22 EST, below its 52-week high of $65.00 and way higher than its 52-week low of $27.80.

Pinnacle Financial Partners, Inc.’s Moving Average

Pinnacle Financial Partners, Inc.’s worth is way above its 50-day moving average of $52.72 and way above its 200-day moving average of $43.51.

LEAVE A REPLY

Please enter your comment!
Please enter your name here